OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutical Sciences is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Editorial Board	369
Aerosol delivery of inhalation devices with different add-on connections to invasively ventilated COPD subjects: An in-vivo study	137
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	108
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia	103
Development of cationic Isometamidium chloride loaded long-acting lipid nanoformulation: optimization, cellular uptake, pharmacokinetics, biodistribution, and immunohistochemical evaluation	100
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue	78
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	77
Molecular characteristics of several drugs evaluated from solvent/water partition measurements: Solvation parameters and intramolecular hydrogen bond indicator	75
3D printed extended-release hydrochlorothiazide tablets	68
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	67
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos	63
Pre-miRNA-149 G-quadruplex as a molecular agent to capture nucleolin	60
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	56
In vitro identification of decreased function genetic variants of ABCB1	55
Impact of protein adsorption during biopharmaceutical manufacture & storage	55
Opportunities of topical drug products in a changing dermatological landscape	55
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	54
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model	53
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	50
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	50
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	49
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation	47
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies	47
Microparticles and multi-unit systems for advanced drug delivery	46
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	44

CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	44
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	42
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	42
Evaluation of Transmission Raman spectroscopy and NIR Hyperspectral Imaging for the assessment of content uniformity in solid oral dosage forms✰	41
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	41
Preclinical characterization of a novel potent core protein assembly modulator for the treatment of chronic hepatitis B viral infection	39
Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study	39
Virtual special issue of Nordic POP: Patient-oriented products	38
Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro	37
Towards optimization of dexamethasone therapy in the maintenance phase of pediatric acute lymphoblastic leukemia: A population pharmacokinetic and pharmacodynamic study of dexamethasone and metabolite	37
Stability evaluation from hydrogen peroxide spiking studies	36
In Vitro and In Vivo Evaluation of Dark Chocolate as Age-appropriate Oral Matrix	36
Role of exosomes in bone and joint disease metabolism, diagnosis, and therapy	36